Retinal neovascular markers in retinopathy of prematurity: Aetiological implications

British Journal of Ophthalmology

Volumn 87, Issue 3, 2003, Pages 275-278

  North, Paula E ^a,d   Anthony, D C ^b   Young, T L ^c   Waner, M ^b   Brown, H H ^a,b   Brodsky, M C ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GLUCOSE TRANSPORTER 1; LEWIS Y ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CAPILLARY HEMANGIOMA; CASE REPORT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE MARKER; EPIRETINAL MEMBRANE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; INFANT; NEOVASCULARIZATION (PATHOLOGY); PLACENTA CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA;

BIOLOGICAL MARKERS; BLOOD-RETINAL BARRIER; DIABETIC RETINOPATHY; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; INFANT; INFANT, NEWBORN; MONOSACCHARIDE TRANSPORT PROTEINS; PHENOTYPE; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; RETINOPATHY OF PREMATURITY; RETROSPECTIVE STUDIES;

EID: 0037341655     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.3.275     Document Type: Article

References (10)

1. Young TL, Anthony DC, Pierce E, et al. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J AAPOS 1997;1:105-10.
2. Stone J, Chan-Ling T, Pe'er J, et al. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci 1996;37:290-9.
3. Pierce EA, Foley ED, Smith LE. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 1996;114:1219-28.
4. Harik SI, Kalaria RN, Andersson L, et al. Immunocytochemical localization of the erythraid glucose transporter: abundance in tissues with barrier functions. J Neurosci 1990;10:3862-72.
5. Kumogai AK, Glasgow BJ, Pardridge WM. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. Invest Ophthalmol Vis Sci 1994;35:2887-94.
6. North PE, Waner M, Mizeracki A, et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001;137:559-70.
7. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: one year outcome - structure and function. Arch Ophthalmol 1990;108:1408-16.
8. North PE, Waner M, Mizeracki A, et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000;31:11-22.
9. Risau W. Induction of blaad-brain barrier endothelial cell differentiation. Ann NY Acad Sci 1991;633:405-19.
10. Chan-Ling T, Stane J. Degeneration of astrocytes in feline retinopathy of prematurity causes failure of the blood-retinal barrier. Invest Ophthalmol Vis Sci 1992;33:2148-59.